Ten years post-menopausal hormone replacement therapy--effect on lipoproteins.

Abstract

Serum lipoproteins were measured in 72 post-menopausal women, 40 of whom had been taking the synthetic oestrogen, mestranol, for a period of 10 yr and 32 of whom had been taking identical placebo tablets. Mestranol therapy was found to increase serum triglycerides, decrease low density lipoprotein (LDL) cholesterol and increase high density lipoprotein (HDL) cholesterol. The increase in HDL cholesterol was due principally to a marked increase in the cardioprotective HDL2 fraction. It is concluded that long-term mestranol therapy has a beneficial effect on serum lipoproteins which may help to protect post-menopausal women against fatal ischaemic heart disease.

• Authors: D M Hart, E Farish, C D Fletcher, C Howie, H Kitchener
• Journal: Maturitas (Maturitas) Vol. 5 Issue 4 Pg. 271-6 (Apr 1984) ISSN: 0378-5122 [Print] Ireland
• PMID: 6738373 (Publication Type: Clinical Trial, Controlled Clinical Trial, Journal Article)

Chemical References

• Lipoproteins
• Lipoproteins, HDL
• Lipoproteins, LDL
• Triglycerides
• Cholesterol
• Mestranol

Topics

• Cholesterol (blood)
• Coronary Disease (prevention & control)
• Female
• Humans
• Lipoproteins (blood)
• Lipoproteins, HDL (blood)
• Lipoproteins, LDL (blood)
• Menopause (drug effects)
• Mestranol (pharmacology, therapeutic use)
• Middle Aged
• Time Factors
• Triglycerides (blood)